In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

Kos, Quintiles market Advicor and Niaspan

Executive Summary

Quintile Transnational's (CRO) marketing unit Innovex will assist with the US commercialization of Kos Pharmaceuticals' (drug delivery) lead products, Niaspan and Advicor, for the treatment of cholesterol disorders.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • Co-Promotion
    • Includes Contract
    • Marketing (Licensing)

Related Companies

UsernamePublicRestriction

Register